Stockreport

Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting

Gamida Cell Ltd. - Ordinary Shares  (GMDA) 
Last gamida cell ltd. - ordinary shares earnings: 11/13 04:01 pm Check Earnings Report
PDF — GDA-201 demonstrated early evidence of clinical activity in patients with non-Hodgkin lymphoma, with multiple complete responses observed —— Research on mechanism of a [Read more]